InvestorsHub Logo
Followers 11
Posts 2288
Boards Moderated 0
Alias Born 07/23/2003

Re: None

Tuesday, 06/21/2005 7:54:20 AM

Tuesday, June 21, 2005 7:54:20 AM

Post# of 11180
Good, News, bad, unfortunately he did it again. Revenues before any single sale. On a first glance, it sounds for real. Maybe we have really a huge winner here.

For dd http://lifetimecontrols.com/


Ingen Technologies Prepares to Launch OxyAlert(TM)
Tuesday June 21, 7:00 am ET
- OxyAlert(TM) Will Impact $45M in Sales First Part of Next Year -

CALIMESA, Calif., June 21 /PRNewswire-FirstCall/ -- Ingen Technologies (OTC: IGTN - News), a medical device manufacturer for physicians and consumer markets, announced today that OxyAlert(TM) would be ready by January 1, 2006.

There are now 8M people prescribed oxygen each year. The OxyAlert(TM) will cost $300 per unit, and can function on any remote oxygen delivery system. The Company is prepared to sell 150,000 OxyAlert(TM) units the first part of next year. This represents revenues of $45M. With the rapid increase of our elderly population, sales are expected to experience a linear increase.

The Company is contracted with Lifetime Controls, Inc., in Arcadia, California, to complete the OxyAlert(TM) development. "Our company has seriously evaluated the OxyAlert(TM) technology and its functional abilities. We are now confident that the device will soon be completed and introduced to the marketplace," said David Kimmich, President of Lifetime Controls, Inc.

OxyAlert(TM) is the second generation of the Company's BAFI(TM) product and falls under both of the issued US patents held by the Company. "This has been a very positive experience for Ingen. We have had to invent new technology for the OxyAlert(TM) so that we could provide technologically advanced features for physicians, hospitals and patients. Lifetime Controls is a very experienced group of engineers with great knowledge in RF technology," said Scott Sand, CEO & Chairman.

The Company continues to increase earnings and launch new medical products in order to build investor confidence and shareholder value. The Company is now engaged in the SEC filings and a move to the OTCBB. "I can only expect a phenomenal increase in share price the day that IGTN is on the OTCBB," said Scott Sand, CEO & Chairman.

About Ingen Technologies

Ingen Technologies (OTC: IGTN - News), in business since 1999, is a medical device manufacturer and service provider for medical and consumer markets both domestic and abroad. Currently increasing revenues are generated from the Company's Secure Balance(TM) program; a medical product line for physicians and hospitals that provide patient services for Balance & Fall Prevention programs. The OxyAlert(TM) is another product line that has two issued US Patents and is a proprietary technology. This product is the second generation development of the Company's initial BAFI(TM) product; a medical safety device that provides wireless and remote monitoring of oxygen delivery systems for patients and small aircraft. Using the same patented and proprietary technology, the Company has the GasAlert(TM) product; a device that interfaces between any gas line and accessory, such as a water heater, dryer, stove or heater, to detect leaks. This is a mass consumer item expected to go to market in 2005.

"Our team of professionals developed medical products for the growing elderly population. These products are proprietary, as well as superior to any of our competition and they allow effective medical product availability to seniors; at the same time the increasing senior population allows for a steady growth in sales and profits," said Scott Sand, CEO & Chairman of Ingen Technologies.

For more information, visit www.ingen-tech.com

Investor Relations Contact: Scott R. Sand, C.E.O & Chairman
Ingen Technologies, Inc.
285 E. County Line Road
Calimesa, CA 92320
800-259-9622
951-675-3266
800-777-1186 FAX
scottsand@ingen-tech.com